Biopharma Insights

Unified Discovery: How ASCEND's Conversational AI Bridges Internal and Public Data for Accelerated Oncology Insights

Over the past decade, BenchSci has been comprehensively collecting, decoding, harmonizing, and structuring insights from tens of millions of biomedical …

Continue ›››

Why European Life Science’s Momentum May Finally Become Unstoppable

Living in Europe and watching the scene firsthand, it seems biotech here doesn’t revolve around a single gravitational center. There’s …

Continue ›››

AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries

As we advance further into the territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) has …

Continue ›››

9 Notable Companies Enabling Decentralized Clinical Trials

Decentralized clinical trials (DCTs) are not a recent invention, but their adoption has accelerated as logistical complexity, geographic dispersion, and …

Continue ›››

9 Companies Using Artificial Intelligence to Fight Infectious Diseases

Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes …

Continue ›››

13 Publicly Traded Companies Developing Longevity Therapeutics

Aging research shifted from watching what happens to testing what can be changed. In the 1930s, lab studies in rats …

Continue ›››

14 Biotechs Utilizing AI-based Research Platforms

According to our internal database, more than 500 life sciences companies in the categories "startups" and "scaleups" are actively using …

Continue ›››

22 Life Science Marketplaces to Try in 2025

A life sciences marketplace is an online platform that operates with a "many-to-many" business logic, hosting multiple suppliers and buyers interacting via various …

Continue ›››

Five Companies Leading the Way in 3D Bioprinting

Lately, bioprinting is shifting from proof-of-concept prints to regulated workflows and early clinical use. In July 2022 in San Antonio, …

Continue ›››

Roche and Manifold Bio's up-to-$2B Deal to Develop Next-Gen Brain Shuttles for Neurological Diseases

Manifold Bio, a Boston-based platform therapeutics company, announced a strategic collaboration and license agreement with Roche to develop several next-generation …

Continue ›››

Companies Making Automated Drug Discovery a Reality

Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a tremendous research …

Continue ›››

7 Biotechs Fighting Rare Diseases With Gene-Editing Tech

Rare diseases sit at an uncomfortable scale: about 30 million people in the U.S., roughly >300 million worldwide. According to …

Continue ›››